Identifying and appraising outcome measures for severe asthma: a systematic review
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Identifying and appraising outcome measures for severe asthma : a systematic review. / 3TR Consortium Respiratory Work Package.
I: The European respiratory journal, Bind 61, Nr. 4, 01.04.2023.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Identifying and appraising outcome measures for severe asthma
T2 - a systematic review
AU - Rattu, Anna
AU - Khaleva, Ekaterina
AU - Brightling, Chris
AU - Dahlén, Sven Erik
AU - Bossios, Apostolos
AU - Fleming, Louise
AU - Chung, Kian Fan
AU - Melén, Erik
AU - Djukanovic, Ratko
AU - Chaudhuri, Rekha
AU - Exley, Andrew
AU - Koppelman, Gerard H.
AU - Bourdin, Arnaud
AU - Rusconi, Franca
AU - Porsbjerg, Celeste
AU - Coleman, Courtney
AU - Williams, Clare
AU - Nielsen, Hanna
AU - Davin, Elizabeth
AU - Taverner, Phil
AU - Romagosa Vilarnau, Sofia
AU - Roberts, Graham
AU - 3TR Consortium Respiratory Work Package
N1 - Publisher Copyright: Copyright ©The authors 2023. For reproduction rights and permissions contact permissions@ersnet.org.
PY - 2023/4/1
Y1 - 2023/4/1
N2 - BACKGROUND: Valid outcome measures are imperative to evaluate treatment response, yet the suitability of existing end-points for severe asthma is unclear. This review aimed to identify outcome measures for severe asthma and appraise the quality of their measurement properties. METHODS: A literature search was performed to identify "candidate" outcome measures published between 2018 and 2020. A modified Delphi exercise was conducted to select "key" outcome measures within healthcare professional, patient, pharmaceutical and regulatory stakeholder groups. Initial validation studies for "key" measures were rated against modified quality criteria from COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN). The evidence was discussed at multi-stakeholder meetings to ratify "priority" outcome measures. Subsequently, four bibliographic databases were searched from inception to 20 July 2020 to identify development and validation studies for these end-points. Two reviewers screened records, extracted data, assessed their methodological quality and graded the evidence according to COSMIN. RESULTS: 96 outcome measures were identified as "candidates", 55 as "key" and 24 as "priority" for severe asthma, including clinical, healthcare utilisation, quality of life, asthma control and composite. 32 studies reported measurement properties of 17 "priority" end-points from the latter three domains. Only the Severe Asthma Questionnaire and Childhood Asthma Control Test were developed with input from severe asthma patients. The certainty of evidence was "low" to "very low" for most "priority" end-points across all measurement properties and none fulfilled all quality standards. CONCLUSIONS: Only two outcome measures had robust developmental data for severe asthma. This review informed development of core outcome measures sets for severe asthma.
AB - BACKGROUND: Valid outcome measures are imperative to evaluate treatment response, yet the suitability of existing end-points for severe asthma is unclear. This review aimed to identify outcome measures for severe asthma and appraise the quality of their measurement properties. METHODS: A literature search was performed to identify "candidate" outcome measures published between 2018 and 2020. A modified Delphi exercise was conducted to select "key" outcome measures within healthcare professional, patient, pharmaceutical and regulatory stakeholder groups. Initial validation studies for "key" measures were rated against modified quality criteria from COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN). The evidence was discussed at multi-stakeholder meetings to ratify "priority" outcome measures. Subsequently, four bibliographic databases were searched from inception to 20 July 2020 to identify development and validation studies for these end-points. Two reviewers screened records, extracted data, assessed their methodological quality and graded the evidence according to COSMIN. RESULTS: 96 outcome measures were identified as "candidates", 55 as "key" and 24 as "priority" for severe asthma, including clinical, healthcare utilisation, quality of life, asthma control and composite. 32 studies reported measurement properties of 17 "priority" end-points from the latter three domains. Only the Severe Asthma Questionnaire and Childhood Asthma Control Test were developed with input from severe asthma patients. The certainty of evidence was "low" to "very low" for most "priority" end-points across all measurement properties and none fulfilled all quality standards. CONCLUSIONS: Only two outcome measures had robust developmental data for severe asthma. This review informed development of core outcome measures sets for severe asthma.
U2 - 10.1183/13993003.01231-2022
DO - 10.1183/13993003.01231-2022
M3 - Review
C2 - 36549712
AN - SCOPUS:85152151943
VL - 61
JO - The European respiratory journal
JF - The European respiratory journal
SN - 0903-1936
IS - 4
ER -
ID: 344982002